Generate Biomedicines
PublicGenerate Biomedicines is now publicly traded
The data on this page reflects Generate Biomedicines's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Went Public
Feb 27, 2026
Last Round
Corporate Funding
Dec 18, 2024
Total Funding Raised
$1.11B
Company Overview
Generate Biomedicines is a biotechnology company that utilizes a generative biology platform to create innovative drugs across various protein modalities and therapeutics.
Sector
Biotech
Verticals
Artificial Intelligence & Machine Learning, HealthTech, Life Sciences
AI Layer
Application
Keywords
Generate Biomedicines Comparables
Compare Generate Biomedicines with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AbSci | 87% | |
| Chai Discovery | 84% | |
| Insilico Medicine | 83% | |
Generate Biomedicines Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO | Feb 27, 2026 | ||||
| Corporate Funding | Dec 18, 2024 | ||||
| Corporate Funding | Sep 24, 2024 | ||||
| Series C | Sep 14, 2023 | ||||
| Series B | Nov 18, 2021 | ||||
Series A | Sep 10, 2020 |
Key People
Founding team and executive leadership
Generate Biomedicines Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Pictet Group | Series C |
| Mirae Asset | Series C |
| Guggenheim Securities | IPO |
| Altitude Life Science Ventures | Series B, Series C |
| MAPS Capital Management | Series C |
| ARCH Venture Partners | Series B, Series C |
| Morningside Ventures | Series B, Series C |
Generate Biomedicines Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
